A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
MOMA Therapeutics
Eli Lilly and Company
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Nammi Therapeutics Inc
National Cancer Institute (NCI)
Beijing Biotech
Parabilis Medicines, Inc.
Exscientia AI Limited
Memorial Sloan Kettering Cancer Center
Conjupro Biotherapeutics, Inc.
Centre hospitalier de l'Université de Montréal (CHUM)
Conjupro Biotherapeutics, Inc.
AstraZeneca
Agenus Inc.
858 Therapeutics, Inc.
City of Hope Medical Center
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Orano Med LLC
University of Southern California
Filamon LTD
Atavistik Bio, Inc
PMV Pharmaceuticals, Inc
AstraZeneca
University of Michigan Rogel Cancer Center
Alterome Therapeutics, Inc.
Rutgers, The State University of New Jersey
Aveni Foundation
Psyence Australia Pty Ltd
ViroMissile, Inc.
Dana-Farber Cancer Institute
Duke University
AstraZeneca
Tizona Therapeutics, Inc
University of Florida
Essen Biotech
Essen Biotech
Mayo Clinic
Clasp Therapeutics, Inc.
IDEAYA Biosciences
National Cancer Institute (NCI)
Unity Health Toronto
Institut Bergonié